NDC50419-0196-30: DIATRIZOATE MEGLUMINE INJECTION.
DIATRIZOATE MEGLUMINE INJECTION. Key specifications include administration: RETROGRADE CYSTOURETHROGRAPHY, primary_container_type: BOTTLE WITH RUBBER STOPPER, SINGLE DOSE, pharmaceutical_vehicle_type: AQUEOUS, medical_designation_and_grade: UNITED STATES PHARMACOPEIA, primary_container_content_quantity: 300.000 MILLILITERS. This part is cataloged in the U.S.
Government catalog under NSN 6505-01-209-1874, indicating validated use in U.S. government and defense logistics supply chains. Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels.
Verify compatibility with your specific system configuration before ordering.
| administration | RETROGRADE CYSTOURETHROGRAPHY |
| special_features | BOTTLE HAS A RATED CAPACITY OF NOT LESS THAN 500 ML; NOT INTENDED FOR INTRAVASCULAR INJECTION; ACTIVE MEDICAMENT MEDICINAL STRENGTH: 30.000 PERCENTAGE, W/V MEGLUMINE DIATRIZOATE ACTIVE INGREDIENT |
| primary_container_type | BOTTLE WITH RUBBER STOPPER, SINGLE DOSE |
| pharmaceutical_vehicle_type | AQUEOUS |
| medical_designation_and_grade | UNITED STATES PHARMACOPEIA |
| total_primary_container_quantity | 8 |
| primary_container_content_quantity | 300.000 MILLILITERS |
| NSN | 6505-01-209-1874 |
| ADMINISTRATION | RETROGRADE CYSTOURETHROGRAPHY |
| PRIMARY CONTAINER CONTENT QUANTITY | 300.000 MILLILITERS |
| MEDICAL DESIGNATION AND GRADE | UNITED STATES PHARMACOPEIA |
| PRIMARY CONTAINER TYPE | BOTTLE WITH RUBBER STOPPER, SINGLE DOSE |
| SPECIAL FEATURES | BOTTLE HAS A RATED CAPACITY OF NOT LESS THAN 500 ML; NOT INTENDED FOR INTRAVASCULAR INJECTION; ACTIVE MEDICAMENT MEDICINAL STRENGTH: 30.000 PERCENTAGE, W/V MEGLUMINE DIATRIZOATE ACTIVE INGREDIENT |
| PHARMACEUTICAL VEHICLE TYPE | AQUEOUS |
| TOTAL PRIMARY CONTAINER QUANTITY | 8 |